Home » Topics » Disease categories and therapies » Immune

Immune
RSS

EMEA hands down positive opinion for Rapamune

Dec. 12, 2000

Immunosuppressive drug in development at Isotechnika shows promise in phase I

Dec. 11, 2000

Epimmune licenses Valentis technology for vaccine development

Dec. 7, 2000

Phase I study results reported in San Francisco for MEDI-507 in GVHD

Dec. 6, 2000

Phase I safety and pharmacokinetic analysis of AP-1903 reported at Hematology meeting

Dec. 4, 2000

ABX-CBL granted orphan drug status for treatment of acute GVHD

Dec. 4, 2000

Clinical evaluation begins for QS-21-containing flu vaccine

Nov. 28, 2000

Heparan sulfate useful for inducing dendritic cell maturation for mounting a primary immune response

Nov. 27, 2000

Immunosuppressive profile of FTY-720 further defined in preclinical studies

Nov. 27, 2000

New Na+/H+ exchange inhibitor protects against lung I/R injury in canine model

Nov. 24, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...